Jinarc 30 mg

JINARC 30 MG tablets contain tolvaptan, a medication used to manage fluid balance in certain conditions. This oral tablet is manufactured by Otsuka Pharmaceutical Co Ltd in Japan.

JINARC 30 MG tablets are primarily used to help manage fluid retention in specific medical conditions. Tolvaptan works by promoting the excretion of excess fluid through urine, which can help alleviate symptoms associated with fluid overload. This medication is often prescribed as part of a broader treatment plan to maintain fluid balance in the body.

Common effects of JINARC 30 MG tablets may include increased urination, which is the primary mechanism of action for tolvaptan. Some individuals might experience dry mouth, thirst, or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

JINARC 30 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with certain medical conditions, such as kidney or liver issues, should inform their healthcare provider before starting tolvaptan. Always store the medication in a cool, dry place away from direct sunlight.

Tolvaptan in JINARC 30 MG tablets may interact with certain medications, including other diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be avoided while taking tolvaptan, as it may exacerbate side effects.